FoodDec 11, 2024
Michael Zakany Jose Madrid Salsa Chipotle Con Queso, Net Wt recall — FDA F-0252-2025
Undeclared Yellow #5 and Yellow #6
Class IIFDA: TerminatedMichael Zakany LLC
Latest records
Latest recalls — page 201
The newest recall records with useful source details are listed here.
FoodDec 11, 2024
Apple Wedge 100% CIDER Pasteurized APPLE WEDGE CIDER 1 Gal recall — FDA F-0249-2025
Patulin. Apple Cider was found to have elevated levels of patulin after receiving analytical testing results from 3rd party laboratory. Lab sample detected 78 ppb; limit is 50 ppb.
Class IIFDA: OngoingApple Wedge LLC
FoodDec 11, 2024
Albertsons Companies recall — FDA F-0248-2025
Meal kits contain cooked chicken which was recalled due to contamination with Listeria monocytogenes
Class IFDA: TerminatedAlbertsons Companies LLC
FoodDec 11, 2024
DYMA BRANDS SYSCO VANILLA INSTANT, NET WT recall — FDA F-0239-2025
After an investigation, the firm discovered that a sifter used in the production of the Dextrose for each product was damaged and introduced metal fragments in the products.
Class IIFDA: CompletedDYMA BRANDS
FoodDec 11, 2024
Albertsons Companies recall — FDA F-0247-2025
Meal kits contain cooked chicken which was recalled due to contamination with Listeria monocytogenes
Class IIFDA: TerminatedAlbertsons Companies LLC
FoodDec 11, 2024
DYMA BRANDS AROMA VITA HOT COCOA MIX, NET WT recall — FDA F-0222-2025
After an investigation, the firm discovered that a sifter used in the production of the Dextrose for each product was damaged and introduced metal fragments in the products.
Class IIFDA: CompletedDYMA BRANDS
FoodDec 11, 2024
DYMA BRANDS REJUV ORIGINALS PINK LEMONADE DRINK MIX NATURAL FLAVOR, NET WT recall — FDA F-0229-2025
After an investigation, the firm discovered that a sifter used in the production of the Dextrose for each product was damaged and introduced metal fragments in the products.
Class IIFDA: CompletedDYMA BRANDS
FoodDec 11, 2024
DYMA BRANDS Sysco Classic Vanilla Instant Pudding & Pie Filling Mix recall — FDA F-0235-2025
After an investigation, the firm discovered that a sifter used in the production of the Dextrose for each product was damaged and introduced metal fragments in the products.
Class IIFDA: CompletedDYMA BRANDS
FoodDec 11, 2024
DYMA BRANDS REJUV ORIGINALS LOW CALORIE ORANGE DRINK MIX NATURAL FLAVOR recall — FDA F-0228-2025
After an investigation, the firm discovered that a sifter used in the production of the Dextrose for each product was damaged and introduced metal fragments in the products.
Class IIFDA: CompletedDYMA BRANDS
FoodDec 11, 2024
DYMA BRANDS Sysco Classic Lemonade Drink Mix Natural Flavor, NET WT recall — FDA F-0232-2025
After an investigation, the firm discovered that a sifter used in the production of the Dextrose for each product was damaged and introduced metal fragments in the products.
Class IIFDA: CompletedDYMA BRANDS
DrugDec 11, 2024
Midlab MAXIM Assure Antibacterial, Chloroxylenol 0.1%, Net Contents: One U.S recall — FDA D-0087-2025
cGMP Deviations: Out of specification results for micro in hand soap products.
Class IIFDA: OngoingMidlab Incorporated
DrugDec 11, 2024
Rising Pharma Holding Duloxetine Delayed-Release Capsules USP, 30 mg, a) 30 count recall — FDA D-0106-2025
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
Class IIFDA: OngoingRising Pharma Holding, Inc.
DrugDec 11, 2024
Aurobindo Pharma USA Cinacalcet Tablets, 90 mg recall — FDA D-0079-2025
cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
Class IIFDA: OngoingAurobindo Pharma USA Inc
DrugDec 11, 2024
Venofer (iron sucrose) Injection, USP 100 mg Elemental Iron per 5 mL (20 mg/mL), 5 mL recall — FDA D-0082-2025
Presence of Particulate Matter: Potential for glass delamination from the vials.
Class IIFDA: OngoingAmerican Regent, Inc.
DrugDec 11, 2024
Diltiazem Hydrochloride Extended-Release Capsules, USP 60 mg, Twice-a-Day Dosage recall — FDA D-0096-2025
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugDec 11, 2024
Diltiazem Hydrochloride Extended-Release Capsules, USP 60 mg, Twice-a-Day Dosage recall — FDA D-0093-2025
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugDec 11, 2024
Midlab Compliance Dishwashing Liquid & Antibacterial Soap, PCMX 0.1%, Net Contents: 1 recall — FDA D-0092-2025
cGMP Deviations: Out of specification results for micro in hand soap products.
Class IIFDA: OngoingMidlab Incorporated
DrugDec 11, 2024
Rising Pharma Holding Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) recall — FDA D-0107-2025
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit
Class IIFDA: OngoingRising Pharma Holding, Inc.
DrugDec 11, 2024
Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets recall — FDA D-0102-2025
Labeling: Not Elsewhere Classified - Wrong NDC number
Class IIIFDA: OngoingZydus Pharmaceuticals (USA) Inc
DrugDec 11, 2024
Venofer (iron sucrose) Injection, USP 50 mg Elemental Iron per 2.5 mL (20 mg/mL), 2.5 mL recall — FDA D-0081-2025
Presence of Particulate Matter: Potential for glass delamination from the vials.
Class IIFDA: OngoingAmerican Regent, Inc.
DrugDec 11, 2024
Diltiazem Hydrochloride Extended-Release Capsules, USP 120mg, Twice-a-Day Dosage recall — FDA D-0098-2025
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.
Class IIFDA: OngoingGlenmark Pharmaceuticals Inc., USA
DrugDec 11, 2024
Venofer (iron sucrose) Injection, USP 100 mg Elemental Iron per 5 mL (20 mg/mL), 5 mL recall — FDA D-0080-2025
Presence of Particulate Matter: Potential for glass delamination from the vials.
Class IIFDA: OngoingAmerican Regent, Inc.
DrugDec 11, 2024
Amerisource Health Services Duloxetine Delayed-Release Capsules, USP, 30 mg recall — FDA D-0100-2025
CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit
Class IIFDA: OngoingAmerisource Health Services LLC
DrugDec 11, 2024
Aurobindo Pharma USA Cinacalcet Tablets, 30 mg recall — FDA D-0077-2025
cGMP Deviations: Presence of N-nitroso Cinacalcet impurity above FDA recommended interim limit
Class IIFDA: OngoingAurobindo Pharma USA Inc
Browse by month
Recent recall archives
Browse recent months with enough recall history for useful comparison.
August 2026149 records · 4 categoriesJuly 2026370 records · 4 categoriesJune 2026375 records · 4 categoriesMay 2026339 records · 4 categoriesApril 2026414 records · 4 categoriesMarch 2026189 records · 4 categoriesFebruary 2026330 records · 4 categoriesJanuary 2026212 records · 4 categoriesDecember 2025388 records · 4 categoriesNovember 2025324 records · 4 categoriesOctober 2025454 records · 4 categoriesSeptember 2025180 records · 4 categories